China

 

African healthcare’s do it yourself plan

The pandemic exposed the fragility of supply chains in emerging markets, and their overdependence on international networks. As delegates at the IFC’s conference in Cape Town, South Africa heard last month, there is a renewed appetite in Africa for self-sufficiency and a coordinated shift towards regionalisation.

MidEuropa buys Optegra

UK, Czechia and Poland-based ophthalmology company Optegra has found a buyer - PE firm MidEuropa has reached a definitive agreement to acquire a majority stake while management and current owners H2 will retain minority stakes.

Private Chinese hospitals in good health

Consulting group L.E.K. has released the results of its analysis Hospital Priorities 2022 (China edition). The survey of 120 hospital executives explains the sector’s focus points and achievements thus far and the implications of these priorities for pharma and medtech firms.

Interview: Dagmar Dvorakova, CEO and Prof. Dr. Roland Staudinger, managing director, Aquilia Health Group

Smart reha, medical malls, how to best deploy new medtech, Fresenius Vamed veterans both, Dagmar and Roland are full of ideas on how to best build and run health care service models from acute hospitals to rehab and outpatient. Two and a half years ago they quit the mothership to set up Aquila which now employs 45 and runs projects in China, SE Asia, Austria, Germany and the Czech Rep.

IHH considers divesting in China

Listed Malaysian hospital group IHH Healthcare is considering a divestment of its loss-making Chinese business, it has told the stock exchange. Parkway Group could sell for US$1bn.

China cracks down on telehealth

The Chinese government has banned remote consultations without prior diagnosis and forbidden AI as a substitute for doctors in a major crackdown on the digital health sector. The new rules have left stocks reeling.

US homecare tech specialist buys Home Instead

US-based homecare tech specialist Honor Technology has acquired Home Instead, the global leader of franchise homecare services. The deal creates a global homecare group worth more than $2.1 billion in homecare revenue.  HBI chats with sources including Home Instead's UK CEO to find out what the deal means for markets outside of the United States.

Find Us